In order to analyse the influence of the nonsense mutation R553X on CFTR gene expression, transcripts from epithelial cells and lymphocytes were examined from nine subjects (one CF patient homozygous for R553X, one CF patient compound heterozygous for R553X/ AF508, four CF carriers heterozygous for R553X, one CF carrier with the genotype AF508/N, and two uncharacterised normal adults). After reverse transcription of the region from exons 10 to 13 to cDNA, fragments of the expected size were amplified from all heterozygous and normal subjects. In three subjects an additional alternatively spliced product was observed, which was found to contain a termination codon. In repeated experiments it was not possible to detect any CFTR mRNA in cells derived from the R553X homozygous patient. Furthermore, in subjects heterozygous for R553X we could not detect by hybridisation with a specific oligonucleotide probe and direct sequencing any CFTR mRNA derived from the R553X allele. However, the wild type product was present in all of these subjects. Our results support the view that nonsense mutations in the CFTR gene can lead to a reduction or absence of cytoplasmic CFTR mRNA.
R553X, one CF carrier with the genotype AF508/N, and two uncharacterised normal adults). After reverse transcription of the region from exons 10 to 13 to cDNA, fragments of the expected size were amplified from all heterozygous and normal subjects. In three subjects an additional alternatively spliced product was observed, which was found to contain a termination codon. In repeated experiments it was not possible to detect any CFTR mRNA in cells derived from the R553X homozygous patient. Furthermore, in subjects heterozygous for R553X we could not detect by hybridisation with a specific oligonucleotide probe and direct sequencing any CFTR mRNA derived from the R553X allele. However, the wild type product was present in all of these subjects. Our results support the view that nonsense mutations in the CFTR gene can lead to a reduction or absence of cytoplasmic CFTR mRNA. (J Med Genet 1993; 30:833-7) Cystic fibrosis (CF) is one of the most common autosomal recessive disorders in white populations. In CF patients, abnormal chloride secretion across the apical membrane of the epithelial cells causes clinical symptoms, including chronic pulmonary disease and pancreatic exocrine insufficiency, together with an increase in the concentration of sweat electrolytes.' The gene responsible for CF, the cystic fibrosis transmembrane conductance regulator (CFTR) Case 8 was a female of German origin and was a symptomless adult. Case 9 was a male of Polish origin and was a symptomless adult.
From cases 1, 3, 4, 5, 6, 8, and 9 nasal epithelial cells were obtained by brushing and blood was also collected from these persons. Lymphocytes were obtained from case 2 (from fresh blood) and case 7 (from a lymphoblastoid cell culture).
RNA EXTRACTION AND cDNA SYNTHESIS Cells obtained by brushing were either transferred to culture medium, centrifuged, washed with PBS, and resuspended in 4 mol/l guanidinium thiocyanate buffer (GTC), or were placed directly into 4 mol/l GTC. Total RNA was extracted from pelleted lymphocytes and epithelial cells using the guanidinium thioisocyanate method.'7 To control the mRNA quality, aliquots of all samples were reverse transcribed to cDNA using a primer within (1) the multidrug resistance (MDR1) gene and (2) the f2-microglobulin (132m) gene and afterwards amplified with primers located in appropriate regions of these genes.'8 Only mRNA preparations from which fragments of the expected size could be amplified were used in the following experiments. A control transcription of a sample without RNA was included in each cDNA synthesis.
For reverse transcription of CFTR mRNA primer 13c (the sequences of the oligonucleotides used in this study are listed in the DNA Thermal Cycler at 42'C for 15 
